Hofheim, Germany

Gert U Kuerzel


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1993-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gert U Kuerzel: Innovator in Neurodegenerative Disorder Treatments

Introduction

Gert U Kuerzel is a notable inventor based in Hofheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurodegenerative disorders. With a total of five patents to his name, Kuerzel's work focuses on enhancing cognitive functions and addressing memory dysfunctions.

Latest Patents

Kuerzel's latest patents include the development of 1-aminoacetamidopyrroles and 1-amino-2-(substituted)pyrroles. These compounds are disclosed as useful glycine partial agonists, which can enhance learning and memory. They are particularly indicated for the treatment of memory dysfunctions associated with neurodegenerative disorders, including Alzheimer's disease and other senile dementias. Additionally, he has patented a process for preparing these compounds, which involves treating a 1-phthalimidopyrrole with a base to yield a 1-aminopyrrole, followed by a reaction with a specific compound to obtain the desired product.

Career Highlights

Throughout his career, Kuerzel has worked with prominent companies such as Hoechst Marion Roussel and Hoechst Roussel Pharmaceuticals. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Kuerzel has collaborated with notable colleagues, including Lawrence L Martin and Raymond W Kosley, Jr. These partnerships have likely enriched his research and development efforts in the pharmaceutical field.

Conclusion

Gert U Kuerzel's innovative work in developing compounds for treating neurodegenerative disorders highlights his significant contributions to medicinal chemistry. His patents reflect a commitment to enhancing cognitive functions and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…